ライフサイエンスコーパス: antiestrogenic

1 hereas others (raloxifene and GW7604) remain antiestrogenic.

2 :ER complex from estrogen-like to completely antiestrogenic.

3 that Pak1 overexpression interfered with the antiestrogenic action of tamoxifen upon the ER transacti

4 were lost in these stable transfectants, but antiestrogenic action was retained.

5 eceptor (ER), all of these compounds exhibit antiestrogenic action when the side chain length is n >

6 taneously preventing mammary carcinogenesis (antiestrogenic action).

7 targets for receptor-mediated estrogenic and antiestrogenic action.

8 posed that tissue-specific estrogenic and/or antiestrogenic actions of certain xenoestrogens may be a

9 apies to exert tissue-specific estrogenic or antiestrogenic activities, this knowledge will be crucia

10 activity in addition to its well-documented antiestrogenic activity and raises the possibility that

11 MCDF displayed antiestrogenic activity at higher concentrations in MCF-

12 addition, CPC showed concentration-dependent antiestrogenic activity half maximal effective concentra

13 sterol and bone metabolism while maintaining antiestrogenic activity in the uterus.

14 have investigated at the molecular level the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-

15 The antiestrogenic activity of CPC, BAK, rotenone, and tricl

16 ential AhR-ER cross-talk is evidenced by the antiestrogenic activity of MCDF and the degradative effe

17 brief, the characterization of structure and antiestrogenic activity of MTA1s peptide highlight its t

18 with aspartate 351 makes this the key to the antiestrogenic activity of raloxifene.

19 ancer is limited by the mixed estrogenic and antiestrogenic activity of selective estrogen receptor m

20 ete agonist activity on the one hand or pure antiestrogenic activity on the other.

21 In all three cases, there was overlap of the antiestrogenic activity with the mitochondrial inhibitor

22 raloxifene in breast cancer depends on their antiestrogenic activity.

23 oxifen is a tamoxifen metabolite with potent antiestrogenic activity.

24 iverse biological effects including striking antiestrogenic activity.

25 Soy isoflavones have antiestrogenic and anticancer properties but also posses

26 nes--a class of phytoestrogens that has both antiestrogenic and anticarcinogenic properties.

27 stewater induced antiandrogenic, estrogenic, antiestrogenic, and retinoid-like activity.

28 de and of similar action as BPA (estrogenic, antiestrogenic, androgenic, and antiandrogenic) in vitro

29 investigate the activities of estrogenic and antiestrogenic compounds in yeast Saccharomyces cerevisi

30 macological behaviour of many estrogenic and antiestrogenic compounds, including the naturally occurr

31 to investigate the effects of estrogenic and antiestrogenic compounds.

32 er that is nonresponsive to estrogen and the antiestrogenic drug tamoxifen.

33 n and thus may contribute toward the loss of antiestrogenic effect of tamoxifen.

34 to understand the mechanisms underlying the antiestrogenic effect of this prototype SERM, we perform

35 The antiestrogenic effect of transfected PR also provides a

36 The antiestrogenic effect was also observed at the level of

37 decreases in ER are not responsible for the antiestrogenic effect.

38 This finding suggests that TCDD may have antiestrogenic effects in the uterine myometrium, in con

39 Antiestrogenic effects of cerulenin and C75 were observe

40 ty rates in Asian countries and the putative antiestrogenic effects of isoflavones have fueled specul

41 research on the mitochondrial inhibitory and antiestrogenic effects of QUATS, including CPC and BAK.

42 However, tumors that are refractory to the antiestrogenic effects of selective ER modulators often

43 The regulation of estrogenic and antiestrogenic effects of selective estrogen receptor mo

44 esults provide a molecular mechanism for the antiestrogenic effects of TCDD and demonstrate the prese

45 Antiestrogenic effects of the compounds were measured by

46 In mechanistic studies, we found that the antiestrogenic effects of the MTA1s peptide were due to

47 The antiestrogenic effects of transfected PR are associated

48 lective estrogen receptor modulator that has antiestrogenic effects on breast and endometrial tissue

49 n experiments conducted with Ishikawa cells, antiestrogenic effects were confirmed by dose-dependent

50 Similar mixed estrogenic/antiestrogenic effects were noted with S30 cells, wherea

51 ed thus far in fish have known estrogenic or antiestrogenic effects, and as such cause the inappropri

52 Proposed mechanisms include estrogenic and antiestrogenic effects, induction of cancer cell differe

53 As well as antiestrogenic effects, there were proestrogenic actions

54 ain flavonoids exhibit antiproliferative and antiestrogenic effects.

55 or, also showed mitochondrial inhibitory and antiestrogenic effects.

56 ds and neutralizes the Asp-351 to produce an antiestrogenic ERalpha complex.

57 -analogues of estradiol have tissue specific antiestrogenic/estrogenic actions, characteristics of se

58 to genistein treatments, suggesting that the antiestrogenic function of genistein is unrelated to the

59 of estrogen can be blocked completely by the antiestrogenic ICI 182,780.

60 uired for this activity as TCDD is no longer antiestrogenic in a mutant cell line that is deficient i

61 Though antiestrogenic in the breast, some antiestrogens have es

62 aken together, these results suggest a novel antiestrogenic mechanism for specific polyamine analogue

63 droxy-N-desmethyltamoxifen), the most potent antiestrogenic metabolite, are reduced in women whose CY

64 A number of fractions showed antiestrogenic or antiandrogenicity potency, with the ne

65 s (PCBs) have been shown to have estrogenic, antiestrogenic, or antiandrogenic properties; as a resul

66 We asked whether the antiestrogenic phytochemical indole-3-carbinol (I3C), fo

67 rast, a mutation at AA 400 does not, and the antiestrogenic properties of raloxifene are retained.

68 -Tetrachlorodibenzo-p-dioxin (TCDD) exhibits antiestrogenic properties, including the inhibition of e

69 as been reported to have weak estrogenic and antiestrogenic properties, to be an antioxidant, to inhi

70 tably expressing either SULT1A1*1 or *2, the antiestrogenic response to OHT was found to be allele-sp

71 nsiveness to estradiol (E2) and also retains antiestrogenic responsiveness to both raloxifene and ICI

72 l AI/SERM, while in breast cancer tissue the antiestrogenic SERM activity of a dual AI/SERM could act

73 ars to be critical for interactions with the antiestrogenic side chain of antiestrogens.

74 eir biology depends on an interaction of the antiestrogenic side chain with amino acid 351.

75 ne (TPE) derivative of tamoxifen without the antiestrogenic side chain.

76 pendent growth often leads to the failure of antiestrogenic tumor therapies.

77 nsteroidal anti-inflammatory) and tamoxifen (antiestrogenic widely used in breast cancer therapy and